Holen Sie sich die Stockscreener-App
204.92
2.96%
-6.26
Handel nachbörslich:
205.19
0.27
+0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$211.18
Offen:
$210.5
24-Stunden-Volumen:
1.56M
Relative Volume:
0.91
Marktkapitalisierung:
$48.22B
Einnahmen:
$244.67B
Nettoeinkommen (Verlust:
$1.68B
KGV:
29.49
EPS:
6.9487
Netto-Cashflow:
$5.51B
1W Leistung:
-4.67%
1M Leistung:
-1.40%
6M Leistung:
+29.14%
1J Leistung:
+56.22%
1-Tages-Spanne:
$204.58
$211.03
1-Wochen-Bereich:
$204.58
$215.00
52-Wochen-Spanne:
$130.52
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
204.92 | 49.69B | 244.67B | 1.68B | 5.51B | 6.9487 |
MCK
Mckesson Corp
|
842.25 | 105.22B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
312.39 | 62.84B | 325.78B | 1.64B | 3.61B | 8.3139 |
HSIC
Henry Schein Inc
|
78.84 | 9.08B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.98 | 1.69B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health: Looking Into The Business Shift (NYSE:CAH) - Seeking Alpha
Lobbying Update: $1,320,000 of CARDINAL HEALTH INC lobbying was just disclosed - Quiver Quantitative
Cardinal Health Inc. stock (US14149Y1082): Is its pharmaceutical distribution scale strong enough fo - AD HOC NEWS
Cardinal Health Inc. stock underperforms Monday when compared to competitors - MarketWatch
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock - Yahoo Finance
Cardinal Health Inc. stock (US14149Y1082): Why does its supply chain role matter more now for U.S. i - AD HOC NEWS
Cardinal Health Targets Community Sites With Advanced Therapies And Partnerships - Yahoo Finance
How Cardinal Health’s (CAH) Advanced Therapies Shift Could Reshape Its Community Care Investment Narrative - Sahm
Cardinal Health Stock (CAH) Opinions on Recent Dividend Payout - Quiver Quantitative
Cardinal Health Inc. stock (US14149Y1082): Is supply chain resilience now the real test for steady r - AD HOC NEWS
New Cardinal Health (CAH) chair receives 381-share RSU equity grant - Stock Titan
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Cardinal Health, Inc. $CAH Shares Acquired by Assetmark Inc. - MarketBeat
Cardinal Health, Inc. (NYSE:CAH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
KBC Group NV Grows Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Report Highlights Community Therapies And Raises New Investor Questions - Sahm
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
State of Alaska Department of Revenue Has $6.24 Million Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Invariant Investment Management Purchases Shares of 5,546 Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Inc. stock (US14149Y1082): Why does its distribution model matter more for investors - AD HOC NEWS
Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings - Cardinal Health
Cardinal Health Report: Expanding Advanced Therapies into Community Care - Intellectia AI
Evercore ISI Trims Cardinal Health (CAH) Target While Maintaining Bullish Rating - Yahoo Finance
Walton Hills warehouse used by Cardinal Health fetches nearly $40 million - Crain's Cleveland Business
Robeco Institutional Asset Management Trims Cardinal Health Holdings - National Today
Burney Co. Boosts Cardinal Health Stock Position by 27% - National Today
Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook - ADVFN
Cardinal Health Stock (CAH) Opinions on Geopolitical Sell-Off and Leadership Shift - Moomoo
Cardinal Health Tops Volume Charts With $280 Million Trade As Specialty Boom Drives Investor Reassessment - Bitget
How The Cardinal Health (CAH) Investment Story Is Shifting As Analysts Rework Their Models - Yahoo Finance
Expanded Actinium‑225 Capacity And Higher EPS Guidance Could Be A Game Changer For Cardinal Health (CAH) - Yahoo Finance
Charles River Labs stock: Margin Boost from Divestitures Signals Buy Opportunity - AD HOC NEWS
Charles River Labs stock: New Asia partnership signals growth potential - AD HOC NEWS
We Ran A Stock Scan For Earnings Growth And Cardinal Health (NYSE:CAH) Passed With Ease - Yahoo Finance
Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032 - GlobeNewswire Inc.
How Investors Are Reacting To Cardinal Health (CAH) Expanding Actinium-225 Capacity For Targeted Alpha Therapies - Sahm
Here’s Why Investing in Cardinal Health Shares Could Benefit Your Portfolio Right Now - Bitget
Cardinal Health (CAH) Gains But Lags Market: What You Should Know - Yahoo Finance Singapore
Cardinal Health Inc. stock rises Wednesday, still underperforms market - MarketWatch
CAH PE Ratio & Valuation, Is CAH Overvalued - Intellectia AI
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now - TradingView
Evercore Maintains Cardinal Health(CAH.US) With Buy Rating, Cuts Target Price to $240 - Moomoo
Cardinal Health Faces "Beat and Raise" Test as Raised Guidance Becomes New Baseline - Bitget
Is Cardinal Health (CAH) Stock Undervalued Right Now? - Yahoo Finance
A Look At Cardinal Health (CAH) Valuation After Expanded Actinium-225 Cancer Therapy Production - Sahm
Cardinal Health, Inc. (CAH) stock price, news, quote and history - Yahoo Finance UK
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - Yahoo Finance
Longtime supervisor sues Cardinal Health over age and gender bias - hcamag.com
Cardinal Health, Inc. (CAH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cardinal Health ER Laceration Tray ACS-SLAC1 | Health Supply 770 INC - primetimes.id
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.29%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):